Patient Data
Age: Elderly
Gender: Male
From the case:
Glioblastoma NOS
{"current_user":null,"step_through_annotations":true,"access":{"can_edit":false,"can_download":true,"can_toggle_annotations":true,"can_feature":false,"can_examine_pipeline_reports":false,"can_pin":false},"extraPropsURL":"/studies/9419/annotated_viewer_json?_c=1669162467\u0026iframe=true\u0026lang=us"}
The brain CT demonstrate an enhancing intra-axial mass at the left parietal lobe.
From the case:
Glioblastoma NOS
{"current_user":null,"step_through_annotations":true,"access":{"can_edit":false,"can_download":true,"can_toggle_annotations":true,"can_feature":false,"can_examine_pipeline_reports":false,"can_pin":false},"extraPropsURL":"/studies/9420/annotated_viewer_json?_c=1669162467\u0026iframe=true\u0026lang=us"}
The MRI shows this lesion to have a low T1 signal intensity and intermediate to high T2 signal intensity associated with significant vasogenic edema which is also seen on the CT images. Moderate restriction of diffusion. The lesion enhances avidly post administration of IV contrast.
Case Discussion
Pathologically proven glioblastoma.
Note: IDH mutation status is not provided in this case and according to the current (2016) WHO classification of CNS tumors, this tumor would, therefore, be designated as a glioblastoma NOS.